SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-15-010627
Filing Date
2015-11-12
Accepted
2015-11-12 16:51:39
Documents
14
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q abio-10q_20150930.htm 10-Q 1322416
2 EX-10.1 abio-ex101_151.htm EX-10.1 29138
3 EX-10.2 abio-ex102_152.htm EX-10.2 30054
4 EX-31.1 abio-ex311_7.htm EX-31.1 8624
5 EX-31.2 abio-ex312_6.htm EX-31.2 8573
6 EX-32.1 abio-ex321_8.htm EX-32.1 11467
7 GRAPHIC g201511120637509844167.jpg GRAPHIC 10917
8 GRAPHIC g201511120638032294014.jpg GRAPHIC 10917
  Complete submission text file 0001564590-15-010627.txt   3789246

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT abio-20150930.xml EX-101.INS 574931
10 XBRL TAXONOMY EXTENSION SCHEMA abio-20150930.xsd EX-101.SCH 32657
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE abio-20150930_cal.xml EX-101.CAL 24695
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE abio-20150930_def.xml EX-101.DEF 79201
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE abio-20150930_lab.xml EX-101.LAB 254889
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abio-20150930_pre.xml EX-101.PRE 182511
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-22873 | Film No.: 151225538
SIC: 2835 In Vitro & In Vivo Diagnostic Substances